In multiple single-cell sequencing datasets of ovarian cancer, we found that FOXP4 was predominantly expressed in malignant tumor cells, while it was expressed at lower levels in stromal cells and immune cells (Fig. 1F). This evidence concerns the gene FOXP4 and neoplasm.